U
Avantor, Inc. AVTR
Recommendation
--
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
$16.37B
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
$0.4692
My Lists My Alerts
Report
Rating
Reward
U
Unrated
Risk
U
Unrated
Rating Factors
Growth Index
Unrated
Efficiency Index
Unrated
Solvency Index
Unrated
Total Return Index
Unrated
Volatility Index
Unrated
Dividend Index
Unrated
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$6.97B
EBITDA (TTM)
$1.30B
EBIT (TTM)
$897.90M
Net Income (TTM)
$321.10M
Balance Sheet
Total Assets (Q)
$12.97B
Total Debt (Q)
$5.66B
Total Liabilities (Q)
$7.72B
Book Value Per Share (Q)
$7.76
Cash Flow
Cash from Operations (TTM)
$870.00M
Cash from Investing (TTM)
-$143.70M
Cash from Financing (TTM)
-$843.70M
Net Change in Cash (TTM)
-$109.20M
Filings
Filing Date
Wednesday, February 14, 2024
Period Date
Sunday, December 31, 2023
Next Filing
Week of Apr 22 and 26 (est)
Price History
Loading...
Beta
--
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
-- - --
52-week High
-- - --
Valuation
Market Cap
$16.37B - Large Cap
Enterprise Value
$21.75B
Price/Sales (TTM)
--
Price/Book (Q)
--
Dividends and Shares
Shares Outstanding
679.20M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.avantorsciences.com
Phone Number
610 386 1700
Address
Radnor Corporate Center
Building One - Suite 200
100 Matsonford Road Radnor, PA 19087
Country
United States
Year Founded
1904
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials... more
Weiss Ratings